On behalf of The Journal of Experimental Stroke & Translational Medicine, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been 13 long years we have started the Journal, now we are celebrating the 13th Anniversary and we are privileged to welcome Experimental Stroke Society.
Cryptogenic stroke (CS) is defined as cerebral ischemia of obscure or unknown origin. The cause of CS remains undetermined because the event is transitory or reversible, investigations did not look for all possible causes, or because some causes truly remain unknown. One third of the ischemic strokes is cryptogenic. Atrial fibrillation is a well-known cause of embolic stroke, and patients with atrial fibrillation generally need to be anticoagulated. Recent evidence suggests that a substantial minority of patients with cryptogenic stroke may have “subclinical” atrial fibrillation - that is, episodes of atrial fibrillation that do not cause significant symptoms, and therefore go unrecognized - Submit Manuscript
When somebody has a stroke, it means that some part of their brain tissue has died. Stroke is usually produced by the interruption of blood flow to part of the brain. Common vascular problems that can lead to stroke include thrombosis (clotting) of blood vessels in the brain, embolus (a blood clot that travels to the brain from somewhere else), and local problems involving blood vessels in the brain, such as an aneurysm or inflammation.
The profile of people who have suffered cryptogenic strokes is generally the same as for people who have suffered strokes of identifiable causes. They tend to be older individuals, who have the typical risk factors for cardiovascular disease.
Journal of Experimental Stroke & Translational Medicine
Email id: firstname.lastname@example.org